September 3, 2012 Issue | Chemical & Engineering News
 
 
 
Copyright © 2012 American Chemical Society
 

September 3, 2012 Issue

Volume 90, Issue 36
09036-cover1-threecxd
September 3, 2012 Issue, Vol. 90 | Iss. 36
Increasingly discouraged by genomics-based discovery, researchers revert to whole-cell screening for tuberculosis treatments
By Lisa M. Jarvis
(pp. 15-24)
Features
Government & Policy
FDA struggles to identify products, optimize review process (pp. 46-48)
Science & Technology
ACS Meeting News: Massive marine supply of metal drives researchers to design selective, durable sorbents (pp. 60-63)
Back Issues
 
A Nonprofit Network For Tuberculosis Drugs
Developing a drug for a neglected disease economically involves wide-reaching partnerships
(pp. 26-27)
 

News of the Week

Membrane Separates Oil And Water With Ease

Materials: Hydrophilic-oleophobic combo could clean up oil spills
(p.9)

Costly Setbacks For Big Pharma

Pharmaceuticals: Bristol-Myers Squibb, Eli Lilly & Co. halt work on drug candidates
(p.10)

Victory For Stem Cell Research

Policy: Court affirms legality of federally funded research on human embryonic stem cells
(p.10)

Arctic Ice Record Low

As of late August, the ice in the Arctic covers the least area it has in three decades
(p.11)

Demystifying Ocean Methane

Chemical Oceanography: Microbes that make methylphosphonate constitute a new biosynthetic pathway
(p.11)

Chemists Gather In Prague

International: European Association for Chemical & Molecular Sciences holds fourth biennial conference
(p.12)

Romney To Focus On Fossil Fuels

Energy Policy: Plan would end subsidies for renewable energy, makes no mention of climate change
(p.12)

DuPont To Divest Automotive Coatings

Planned sale to private equity firm follows acquisitions in biobased materials
(p.13)

Wiring Up Living Tissue

Sensing: Merging biology and electronics could lead to smart implants and prosthetics
(p.13)
 

Departments

09036-cover2-pa824

Business

Repurposed labs to work on drug discovery and metabolic testing
(pp. 40-43)
Making transgenic animals to produce drugs has matured, but few products have come to market
(pp. 34-38)
Fee-for-service contracting rises in an opportunistic approach to drug discovery research
(pp. 30-33)
Increasingly discouraged by genomics-based discovery, researchers revert to whole-cell screening for tuberculosis treatments
(pp. 15-24)
Developing a drug for a neglected disease economically involves wide-reaching partnerships
(pp. 26-27)
09036-govpol2-tickercxd

Government & Policy

Scientists oppose financial disclosure requirements of insider-trading ban
(pp. 50-54)
Office of Personnel Management asks federal scientists, engineers to volunteer
(p.56)
FDA struggles to identify products, optimize review process
(pp. 46-48)

Education

Workshop for starting chemistry faculty focuses on developing teaching skills
(p.76)
Instructors aim to make science more relevant for undergrads not majoring in the subject
(pp. 74-75)
09036-scitech4-smithcxd

Science & Technology

ACS Meeting News: University of Pennsylvania chemist fostered electrochemistry, ACS, and chemical history
(pp. 72-73)
ACS Meeting News: Chemists discuss the growing role of natural products in developing new pesticides
(pp. 64-67)
ACS Meeting News: With new methods to modify protein backbones, chemists probe what makes proteins stable
(pp. 68-71)
ACS Meeting News: Massive marine supply of metal drives researchers to design selective, durable sorbents
(pp. 60-63)

Career & Employment

Tips for scientists preparing a talk about their work
(p.80)

Editor's Page

Letters

Letters(pp. 6-7)